Example: tourism industry
full prescribing information - CSL Behring
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Helixate FS safely and effectively. See full prescribing information for Helixate FS.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
(2.3) • PI: Administer at regular intervals from daily up ...
labeling.cslbehring.com14.1 Primary Immunodeficiency (PI) 14.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 15 REFERENCES 16 HOW SUPPLIED/STORAGE AND HANDLING 17 PATIENT COUNSELING INFORMATION * Sections or subsections omitted from the full prescribing information are not listed. HIGHLIGHTS OF PRESCRIBING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
labeling.cslbehring.com12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.3Pharmacokinetics 13 NONCLINICAL T OXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility Animal Toxicology and/or Pharmacology 14 CLINICAL STUDIES REFERENCES 16 HOW SUPPLIED/STORAGE AND HANDLING PATIENT COUNSELING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
labeling.cslbehring.com5.1 Thromboembolic Events (VWD Patients) 5.2 Monitoring for Intravascular Hemolysis 5.3 Monitoring VWF:RCo and FVIII Levels 5.4 Transmission of Infectious Agents 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience 6.2 Postmarketing Experience 7 DRUG INTERACTIONS 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Labor and Delivery
(2.3) HIZENTRA •Infusion sites – Up to 8 ... - CSL Behring
labeling.cslbehring.como Ensure that patients have received Immune Globulin Intravenous (Human) (IGIV) treatment at regular intervals for at least 3 months. o Obtain the patient’ s serum IgG trough level to guide subsequent dose adjustments (see below, under Dose Adjustment).
Related documents
HIGHLIGHTS OF PRESCRIBING INFORMATION …
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AUBAGIO® safely and effectively. See full prescribing information for AUBAGIO.
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
www.astellas.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VESIcare® safely and effectively. See full prescribing information …
XHANCE™ Full Prescribing Information
www.xhance.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE XHANCE™ nasal spray is indicated for the treatment of nasal polyps in patients 18 years of age or older.
HIGHLIGHTS OF PRESCRIBING INFORMATION • …
packageinserts.bms.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Unresectable or Metastatic Melanoma • OPDIVO® (nivolumab) as a single agent is indicated for the treatment of patients
FULL PRESCRIBING INFORMATION: CONTENTS* 1 …
www.bausch.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VYZULTA safely and effectively. See full prescribing information …
US-18970 HIGHLIGHTS OF PRESCRIBING …
www.azpicentral.comUS-18970 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MOVANTIK safely and effectively.